Home > Formulary : Paediatric > Recent Decisions > 2020 >
Tuesday 8th September 2020
At the meeting on the 8th September the following decisions were agreed
New Drug Requests
-
Desmopressin oral tablets and oral lyophilisates (TLS Green) for primary nocturnal enuresis
-
Oxybutynin modified release tablets (TLS Amber no SCP)
-
Ropivacaine (TLS Red)
-
Tapentadol oral solution 20mg/ml (TLS Red)
Approved
Shared Care Protocols/TLS changes
New SCPs
Updated SCPs
Other decisions:
- In light of oxybutynin modified release approval as TLS Amber no SCP status, it was agreed to change other antimuscarinics to TLS Amber no SCP status also - solifenacin, oxybutynin immediate release, tolterodine